America’s love of free markets extends to its fertility clinics
By Staff,
The Economist
| 03. 03. 2021
Thanks to an absence of regulation, America is a notable exporter of human sperm
Every time one of America’s genetic-testing companies advertises a deal on DNA kits, Michael (not his real name) braces himself for what may follow: a message from one of his hitherto unknown offspring. Three decades ago, as a student at the University of Houston, Michael became a sperm donor; the clinic would “pull me out of retirement”, he says, every time a customer wanted to expand their family. So far, the 55-year-old knows of around 60 children (and a dozen grandchildren) he has sired in addition to the four teenagers he shares with his wife; he suspects the true number is closer to 100.
“I could write a book,” he says, about the lifelong consequences of what had seemed, at the time, like an easy buck and an incentive to live healthily (he steered clear of heavy drinking and drugs to preserve his sperm's motility). Several children contact him regularly. He has been surprised by how many had been led to believe the father who brought them up was their biological parent: “Sometimes they’re very angry they’ve been lied to...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...